食管癌辅助治疗预后和预测生物标志物数据集：术前血清钠水平（数据表2）

数据集获取（Figshare）

• 源站标题：DataSheet_2_Preoperative Serum Sodium Level as a Prognostic and Predictive Biomarker for Adjuvant Therapy in Esophageal Cancer.xlsx
• DOI：10.3389/fonc.2020.555714.s002
• 发布日期：2021-01-21
• 文件数：1 个
• 文件总体积：22.87 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/DataSheet_2_Preoperative_Serum_Sodium_Level_as_a_Prognostic_and_Predictive_Biomarker_for_Adjuvant_Therapy_in_Esophageal_Cancer_xlsx/13619735

命令行下载

curl -L -o "DataSheet_2_Preoperative Serum Sodium Level as a Prognostic and Predictive Biomarker for Adjuvant Therapy in Esophageal Cancer.xlsx" "https://ndownloader.figshare.com/files/26139311"

文件清单

• DataSheet_2_Preoperative Serum Sodium Level as a Prognostic and Predictive Biomarker for Adjuvant Therapy in Esophageal Cancer.xlsx（22.87 KB）

文件总体积 22.87 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

BackgroundLow serum sodium has been associated with unfavorable outcome in several cancers. The prognostic value of serum sodium in esophageal carcinoma (EC) remains unclear. This study aimed to investigate preoperative serum sodium in association with outcome and survival benefit of adjuvant therapy for patients with EC.
MethodsPreoperative serum sodium and clinicopathological indexes were retrospectively analyzed in 2155 patients who underwent esophagectomy at Sichuan cancer hospital. Overall survival (OS) and disease-free survival (DFS) were analyzed by using Kaplan-Meier method and Cox regression. Benefit of adjuvant therapy was estimated by using Propensity Score Matching.
ResultsThe incidence of hyponatremia and hypernatremia were 2% (43/2155) and 3.5% (76/2155) in treatment-naive patients. Both sodium disorders indicated unfavorable OS (hyponatremia, adjusted HR[95% CI] = 1.78[1.2–2.62]; hypernatremia, adjusted HR = 1.52[1.1–2.11]) and DFS (hyponatremia, adjusted HR[95% CI] = 1.52[1.03–2.23]; hypernatremia, adjusted HR = 1.45[1.06–1.99]). Decreased sodium concentrations within the normal range were associated with poor OS and DFS. Postoperative adjuvant therapy was associated with improved three-year OS (56.6 vs. 40%; adjusted HR = 0.55 [95% CI, 0.41–0.73]) and DFS (51.9 vs. 36.2%; adjusted HR = 0.63 [95% CI, 0.48–0.83]) versus surgery alone in patients with low serum sodium (Na These results suggested that low preoperative serum sodium is associated with poor outcome in EC patients, and may predict survival benefit of adjuvant therapy.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fonc.2020.555714.s002（source: https://frontiersin.figshare.com/articles/dataset/DataSheet_2_Preoperative_Serum_Sodium_Level_as_a_Prognostic_and_Predictive_Biomarker_for_Adjuvant_Therapy_in_Esophageal_Cancer_xlsx/13619735）。